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Abstract
Attachment to epithelial cells in the respiratory tract is a key event in Bordetella 
pertussis colonization. Filamentous haemagglutinin (FHA) is an important viru­
lence factor mediating adhesion to host cells. In this study, the relevance of the 
interaction between FHA and adenylate cyclase toxin (ACT) during bacterial 
attachment was investigated. Mutants lacking either FHA or ACT showed 
significantly decreased adherence to epithelial respiratory cells. The use of several 
ACT-specific monoclonal antibodies and antiserum showed that the decrease in 
attachment of strains lacking ACT expression could not be explained by the 
adhesin-like activity of ACT, or a change of any of the biological activities of ACT. 
Immunoblot analysis showed that the lack of ACT expression did not interfere with 
FHA localization. An heparin-inhibitable carbohydrate-binding site is crucial in 
the process of FHA-mediated bacterial binding to epithelial cells. In the presence of 
heparin attachment of wild-type B. pertussis, but not of the isogenic ACT defective 
mutant, to epithelial cells was significantly decreased. These results suggest that 
ACT enhances the adhesive functions of FHA, and modifies the performance of the 
FHA heparin-inhibitable carbohydrate binding site. We propose that the presence 
of ACT in the outer membrane of B. pertussis to play a role in the functionality of 
FHA.
Introduction
Bordetella pertussis, the etiological agent of whooping cough, 
has several virulence factors under the control of a two- 
component signal transduction system encoded by the 
bvgAS regulatory locus. The BvgAS system mediates the 
transition between virulent (Bvg+), intermediate (Bvg1) and 
avirulent (Bvg —) phases characterized by distinct patterns of 
gene expression (Lacey, 1960; Cotter & DiRita, 2000; Deora 
et al., 2001; Williams et al., 2005). Some of these virulence 
factors are regarded as adhesins mainly involved in bacterial 
attachment to the host cells, i.e. filamentous haemagglutinin 
(FHA), pertactin and fimbriae, while others, such as adeny­
late cyclase-hemolysin toxin (ACT) contribute to subse­
quent host colonization (Mattoo & Cherry, 2005)
The Bvg+ phase is characterized by the presence of the 
majority of the virulence factors that are encoded by the so- 
called vir-activated genes (vags), which can be induced 
experimentally by growing bacteria at 37 C in standard 
Bordetella growth medium. The Bvg— phase can be induced 
by the exposure to modulators, including MgSO4, nicotinic 
acid or low temperatures. This results in the suppression of 
vags and the expression of vir-repressed genes (vrgs), which 
encode proteins whose function is still under investigation. 
Exposure to ‘semi-modulating’ concentrations of modula­
tors or temperatures between 30 and 37 °C results in the 
transition to the Bvg1 phase. This phase is characterized by 
activation of early, including fhaB, but not late, such as cyaA 
(which encodes ACT), vags, and the lack of transcription of 
vrgs (Cotter & DiRita, 2000; Deora et al., 2001).
Previous studies suggested that changes in the microenvir­
onment regulate BvgAS-mediated expression of specific 
virulence factors in vivo. This might be relevant for Bordetella 
pathogenesis and persistence (Kinnear etal., 2001; Veal-Carr 
& Stibitz, 2005; Vergara-Irigaray et al., 2005).
It has been demonstrated that a physical association 
occurs between two of the main virulence factors under the 
BvgAS control, FHA and ACT, and that FHA is necessary for 
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ACT retention in the outer membrane. FHA localization was 
shown unchanged in the absence of ACT, as determined by 
Western blot analysis (Zaretzky et al., 2002). However, the 
functional relevance of ACT-FHA coexpression has not been 
studied in detail.
The purpose of this study was to investigate the influence 
of the association between FHA and ACT, two virulence 
factors with different kinetics of expression during phase 
modulation, on the bacterial interaction with respiratory 
epithelial cells, a key event during Bordetella pertussis 
colonization of the host.
Materials and methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1. All 
B. pertussis strains were grown at 37 C for 2-3 days on 
Bordet-Genou agar plates (Difco Laboratories) supplemen­
ted with 15% defibrinated sheep blood (ABG). Bacteria were 
then subcultured on ABG for 24 h. Antibiotics were added to 
culture media for experiments as indicated, using the 
following concentrations: kanamycin, 25 pg ml. ’; strepto­
mycin, 50 pg mL ’.
For comparative studies of B. pertussis Bvg phenotypes, 
Tohama I was grown on ABG containing either 50 mM of 
MgSO4 or no modulator, and further subcultured in Stai- 
ner-Scholte (SS) medium with or without 50 mM of mod­
ulator, respectively. Next, both bacterial cultures were 
replicated in SS medium without modulator, harvested at 
0, 6, 9, 12 and 24 h, washed and suspended in either 
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco 
BRL, Gran Island, NY), or PBS at a final concentration of 
10” bacteria mL ', and were used in attachment assays or 
Western blot analysis.
Cells and growth conditions
The human alveolar epithelial cell line A549 (human lung 
type II pneumocyte) (ATCC CCL185, Rockville, MD) was 
cultured in DMEM supplemented with 10% of FCS, 
100 UmL 1 penicillin, and lOOpgmL 1 streptomycin (Sig­
ma, St Louis, MO) (complete medium) at 37 °C in 5% CO2. 
Routine subcultures for A549 pneumocytes were done at 
1 :3 split ratios by incubation with 0.05% trypsin-0.02%
Table 1. Strains of Bordetella pertussis used in this study
Strain Phenotype Reference
Tohama I Virulent phase (wild type) Sato & Arai (1972)
BpGR4 FHA -, derivative of Tohama I Locht et a/. (1992)
Bp3183 ACT -, derivative of Tohama I Weiss et al. (1989)
Bp537 Bvg - phase locked, derivative 
of Tohama I
Reiman etal. (1989)
EDTA for 5 min at 37 C. For Bordetella adherence assay, 
epithelial cells were cultured to 80% confluence.
Sera and monoclonal antibodies
The following monoclonal antibodies (mAb) against B. 
pertussis proteins were used: 2A12 (IgG2a) against B. 
pertussis ACT, 6E1 (IgGl) against B. pertussis ACT (both 
kindly provided by Dr Hewlett, University of Virginia, 
USA), and 37F3 (IgGl) against B. pertussis FHA kindly 
provided by The Netherlands Vaccine Institute (Bilthoven, 
the Netherlands). Polyclonal mouse anti-ACT B. pertussis 
antiserum was generated as described by Hozbor et al. 
(1995). All antibodies were used in nonagglutinating con­
centrations.
Attachment assays
Attachment assays were performed as described in Rodri- 
guez et al. (2006) with minor modifications. Briefly, cells 
were seeded on glass coverslips in 24-well tissue culture 
plates (Nunc, Rockside, Denmark) and incubated for 18 h. 
Monolayers were washed twice with DMEM supplemented 
with 10% FCS without antibiotics prior to incubation with 
selected strain of B. pertussis (ratio: 100 bacteria per cell) in 
the absence or presence of monoclonal antibodies 
(30 pg ml. 1), mouse anti-ACT serum (10% v/v) or murine 
preimmune serum, or bovine mucosal heparin (Mr; 3000; 
Sigma; 1 mg ml. !). Bacterial inocula were quantified by 
plating appropriate dilutions on ABG. To facilitate bacterial 
interaction with epithelial cells, plates were centrifuged for 
5 min at 640 g. Adherence of bacteria to A549 cells was 
determined after 2 h of incubation at 37 °C with 5% CO2. 
No changes in the number of viable A549 cells were detected 
after incubation with bacteria. Experiments were stopped by 
washing the monolayers with DMEM medium supplemen­
ted with 10% FCS, prior to fixation with methanol. Cells 
were stained using crystal violet and bacterial adherence was 
quantified by microscopy. The number of adherent bacteria 
per cell was estimated by a microscopic examination of 20 
randomly selected fields showing a minimum of seven 
epithelial cells per field. All experiments were carried out at 
least three times in duplicate.
Immunoblot analysis
Bacterial suspensions were lyzed with Laemmli sample 
buffer and run on 12,5% sodium dodecyl sulphate-poly- 
acrilamide gel (SDS-PAGE; 12,5% polyacrylamide; Laemm­
li, 1970). Proteins were transferred to polyvinylidene 
fluoride (Immobilon PVDF Millipore) sheets (Towbin 
et al., 1992) and incubated with mouse monoclonal anti- 
FHA or polyclonal anti-ACT antibodies. The immunochem­
ical detection was performed using alkaline phosphatase- 
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conjugated goat antimouse IgG (Jackson Immuno Research, 
BaltimorePike).
Statistical analysis
Differences between the results of the experiments were 
evaluated by means of anova or f-lesl. Significance was 
accepted at P < 0.05. Results are shown as means and SD.
Results
Lack of ACT expression decreases B. pertussis 
attachment to alveolar epithelial cells
In order to evaluate the relevance of ACT expression on 
FHA-mediated B. pertussis interaction with human respira­
tory epithelial cells we compared the attachment of the B. 
pertussis wild-type strain and the isogenic ACT-deficient 
mutant (Bp3183) to A549 cells. Bordetella pertussis FHA 
deficient mutant (BpGR4) and B. pertussis phase-locked 
Bvg— mutant (Bp537) were included as controls. The lack 
of FHA (BpGR4) caused a significant decrease (P < 0.05) in 
the number of attached bacteria (Fig. 1). Attachment ratios 
of the B. pertussis strain lacking the expression of all 
virulence factors (Bp537) and BpGR4 to epithelial cells were 
very similar, indicating that FHA is the main Bvg-controlled
Strain
Fig. 1. Role of virulence factors on Bordetella pertussis attachment to 
human epithelial respiratory cells. Wild-type B. pertussis and mutant 
strains defective in the expression of FHA (BpGR4), ACT (Bp3183), or all 
Bvg-regulated virulence factors (Bp537) were allowed to adhere to A549 
cells at a multiplicity of infection (MOI) of 100. Data represents 
mean±SD of at least four independent experiments. The attachment 
levels of Bp537 and BpGR4 were significantly different from the attach­
ment of both Bp3183 and the wild-type strain (*P < 0.05). Furthermore, 
attachment of Bp31 83 was different from that exhibited by the wild-type 
strain (**P < 0.05).
adhesin in this system. However, the absence of ACT 
significantly reduced bacterial adhesion compared the wild­
type strain (P < 0.05), but to a lesser extent than bacteria 
lacking FHA.
Antibodies against ACT fail to block B. pertussis 
attachment to A549
Next, we evaluated the attachment of wild-type B. pertussis 
in the presence of several ACT-specific antibodies. Mouse 
anti-ACT serum and anti-ACT monoclonal antibodies with 
different specificities were tested. MAb 6E1, was shown to 
reduce the hemolytic activity (Hly) but did not change 
adenylate cyclase enzymatic activity (AC) of ACT. MAb 
2A12, blocks the binding of ACT to the host cell membrane, 
and both enzymatic activities of ACT, Hly and AC (Lee et al., 
1999). These ACT-specific mAbs, as well as the ACT-specific 
polyclonal antiserum, did not reduce the level of attachment 
of wild-type B. pertussis to epithelial cells (P < 0.05; Fig. 2). 
In contrast, the attachment level of wild-type B. pertussis was 
significantly decreased in the presence of anti-FHA 
(P < 0.05). To further evaluate a possible role of ACT as a 
minor adhesin we tested the effect of ACT-specific anti­
bodies on the epithelial attachment of the FHA deficient
______________ Bp wt___________ Bp GR4Bp 3183
Fig. 2. Effect of anti-ACTand anti-FHA antibodies on the attachment of 
Bordetella pertussis to human respiratory epithelial A549 cells. Bordetella 
pertussis wild type or a mutant strain defective in the expression of ACT 
(Bp3183) were added to A549 cell monolayers (MOI of 100) in the 
presence of murine preimmune serum (10% v/v), murine ACT-specific 
antiserum (10% v/v), two different monoclonal antibodies against ACT 
(30ugmL or monoclonal antibodies against FHA (30 ug mL '). Values 
are the mean ± SD of at least four separate experiments.
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(a) Bpwt Bp 3183 Bp GR4 kDa
Fig. 3. The absence of ACT does not affect cellular FHA expression. 
Western blot analysis of whole-cell lysates of Bordetella pertussis wild 
type; Bp3183 (ACT-) and BpGR4 (FHA-). Bacterial cell suspensions 
were run in SDS-PAGE 12,5%, and transferred to PVDF membranes. 
Immunoblot was performed with mouse anti-FHA (a) or anti-ACT (b) 
antibodies. Migration of molecular mass markers (kDa) is indicated on 
the right.
mutant, and the effect of anti-FHA in combination with 
anti-ACT antibodies on the wild-type strain attachment 
level. The addition of anti-ACT antibodies did not decrease 
adherence of the FHA deficient mutant to epithelial cells. 
Similarly, addition of ACT-specific antibodies did not 
further decrease the attachment level of wild-type bacteria 
in the presence of anti-FHA antibodies (Fig. 2). These results 
show that ACT does not act as an adhesin in the interaction 
of B. pertussis with A549 cells. The attachment level of B. 
pertussis lacking the expression of ACT was found to be 
lower in the presence of anti-FHA antibodies, confirming 
the involvement of FHA in the attachment of ACT-deficient 
mutant B. pertussis (Fig. 2).
The lack of ACT does not affect FHA cellular 
expression
FHA expression is essential for ACT association with the 
bacterial surface (Zaretzky et al., 2002). Therefore, we 
investigated whether the lack of ACT affects FHA expression, 
which could explain the decreased bacterial attachment of 
the ACT-deficient mutant. As found by others (Zaretzky 
et al., 2002), western blot analysis of wild-type and the FHA- 
deficient BpGR4 strain showed a reduction of bacterial ACT 
in the absence of FHA. Conversely, the lack of ACT did not 
affect the expression of FHA (Fig. 3).
Differential expression of ACT in response to 
modulating factors affects bacterial attachment 
to epithelial cells in vitro
The differential regulation of the bvg- activated promoters 
shows that B. pertussis transiently expresses FHA but not 
ACT during phase modulation. We here investigated the 
effect of a B. pertussis phase shift on the level of attachment 
to A549 cells in order to further evaluate the effect of the lack 
of ACT expression. Bacteria grown in the presence of 
modulating concentrations of MgSO4 for 21 h were further 
subcultured under nonmodulating conditions for different 
periods of time (Bp out-mod) and tested for their ability to 
attach to respiratory epithelial cells. Virulent B. pertussis 
wild-type and ACT-deficient mutant strains were grown in 
parallel under nonmodulating conditions to be used as 
controls. Additionally, the ACT-deficient mutant was also 
grown in the presence of modulating concentrations of 
MgSO4 for 21 h, further subcultured under nonmodulating 
conditions for different periods of time (Bp3183 out-mod) 
and tested for its ability to attach to respiratory epithelial 
cells. Figure 4 shows that immediately after shifting to 
nonmodulating conditions, bacteria (Bp out-mod/0) 
attached significantly less (P < 0.05) than both the virulent 
B. pertussis wild-type strain and Bp3183. Bacteria collected 
after 6h of culture under nonmodulating conditions (Bp 
out-mod/6) showed significantly higher attachment ratios 
(P < 0.05) than those exhibited by Bp out-mod/0, but 
similar to those of the B. pertussis ACT-deficient mutant. 
Bacteria cultured for 9 h under nonmodulating conditions 
attached to epithelial cells significantly better (P < 0.05) 
than bacteria harvested after 6 h, although the attachment 
ratio of these bacteria was still lower (P < 0.05) than that of 
the wild-type strain. After 12 h of incubation under non­
modulating conditions, bacterial attachment reached 
the level exhibited by wild-type bacteria. After 6 h of 
culture under nonmodulating conditions, no further in­
crease in the expression of cellular FHA was detected (Fig. 
4). Notably, the evolution of bacterial attachment ratios 
seems to correlate with the time-dependent level of ACT 
expression. Accordingly, the increase of adherence of the 
ACT mutant strain after shifting to nonmodulating condi­
tions (Bp3183 out-mod) proved similar to that exhibited by 
the wild-type strain during the first 6 h. After 9 h of 
incubation under nonmodulating conditions, the attach­
ment level of the wild-type strain, already expressing ACT 
(Fig. 4a), proved significantly higher (P < 0.05) than that 
exhibited by the ACT-deficient mutant under the same 
culture conditions.
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(a)
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Control 0
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I I Bp 3183 
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Fig. 4. Phenotypic modulation and its effect on the attachment of 
Bordetella pertussis to epithelial respiratory cells. Bordetella pertussis 
wild-type and ACT-deficient mutant <Bp31S3) strains were grown in 
presence of 50 mM of MgS04 for 21 h and then cultured in the absence 
of MgS04 (Bp out-mod and Bp3183 out-mod, respectively) for 0, 6, 9, 12 
or 24 h. Additionally, wild-type (virulent Bp) and ACT-deficient mutant 
(Bp3183) strains were grown in parallel in the absence of modulator 
agent for 0, 6, 9, 12 or 24 h, to be used as controls. ACT and FHA 
expression of Bp out-mod grown under nonmodulating for different 
periods of times was analysed by Western blot analysis, as described in 
the legend of Fig. 3. ACTand FHA expression of virulent Bp was tested as 
a control (a). Bp out-mod, Bp3183 out-mod, virulent Bp, and Bp3183 
grown under nonmodulating conditions for different periods of times 
were allowed to attach to the A549 cells (MOI 100) (b). Virulent Bp 
attachment level (control) was set as 100%. Data are the mean of at least 
three independent experiments.
ACT expression affects heparin-inhibitable 
binding activity of FHA
The heparin-inhibitable binding activity of FHA is largely 
responsible for the attachment of B. pertussis to epithelial 
cells (Menozzi et al., 1991; Hannah et al., 1994; Menozzi 
etal., 1994). We therefore evaluated whether the interaction 
between ACT and FHA is relevant for the functionality of 
this binding domain. To this end, the attachment of B. 
pertussis wild-type and ACT-deficient mutant strains was 
compared in the presence of heparin. The presence of 
heparin led to a significant decrease (P < 0.05) in adherence 
of the B. pertussis wild-type strain but did not alter the
None Heparine
Fig. 5. Effect of heparin on B. pertussis attachment to human respira­
tory epithelial A549 cells. Wild-type B. pertussis, FHA-deficient mutant 
(BpGR4), or ACT-deficient mutant (Bp3183) strains were added to A549 
cell monolayer (MOI of 100) in the presence, or absence of heparin 
(1 mg mL_1). Results are expressed as the number of bacteria adhered per 
cell. Values are the mean ± SD of at least four separate experiments.
attachment level of the isogenic FHA-deficient mutant (Fig. 
5). These results confirmed the involvement of the heparin- 
binding domain in the FHA-mediated bacterial attachment 
to respiratory cells. The attachment level of the B. pertussis 
ACT-deficient mutant to A549 cells was not affected 
(P < 0.05) by the presence of heparin, suggesting that 
FHA-ACT interaction on bacterial surfaces is relevant for 
the activity of this FHA binding domain (Fig. 5).
Discussion
Bordetella pertussis is an obligate human pathogen that 
resides in the respiratory tract during infection. Bacterial 
adhesins promote attachment to host cells, which is a key 
event in pathogenesis. Bordetella pertussis is able to adhere to 
various cell types through different adhesins. Fimbrial-type 
protein (Fimbriae) was found implicated in B. pertussis 
binding to HEp-2 (van den Berg et al., 1999) cells and 
monocytes (Hazenbos et al., 1995a,b), while pertactin, an 
outer membrane protein, contributes to the binding to 
HEp-2 (van den Berg et al., 1999) and CHO (Leininger 
et al., 1991) cell lines. FHA, the main adhesin of B. pertussis, 
was shown to be involved in bacterial attachment to both 
(human) ciliated (Tuomanen & Weiss, 1985; Tuomanen 
et al., 1988) and nonciliated cells (Prasad et al., 1993; 
Menozzi et al., 1994; van den Berg et al., 1999; Rodriguez 
et al., 2006).
Apart from adhesins, B. pertussis produces toxins that are 
involved in host immune evasion and cause pertussis 
symptoms. ACT is a bacterial enzyme that contains two 
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functionally separated domains (Hanski et al., 1989; Ehr­
mann et al., 1991). One of them is activated by host cell 
calmodulin and catalyses the production of intracellular 
cAMP from ATP, thus intoxicating the host cell. The second 
domain induces hemolysis of erythrocytes. ACT has been 
recently shown to be physically associated with FHA on the 
B. pertussis surface (Zaretzky et al., 2002). Although B. 
pertussis mutants lacking FHA were found to release sig­
nificantly more ACT due to a defective retention on the 
bacterial surface (Weiss etal., 1983), our results confirm that 
the lack of ACT does not affect cellular FHA expression 
(Zaretzky et al., 2002), and additionally show that ACT- 
deficiency causes a significant decrease in bacterial attach­
ment. Interestingly, similar results were obtained using 
ciliated epithelium to test the attachment of Bordetella 
mutant strains lacking ACT expression in the outer mem­
brane of the bacteria (Tuomanen & Weiss, 1985; Edwards 
et al., 2005), whereas a B. pertussis ACT mutant expressing 
nontoxic ACT on the bacterial surface was found to attach to 
respiratory cells in a similar way to the wild-type strain 
(Ishibashi et al., 2001). Combined, these results seem to 
indicate that expression of ACT in the bacterial surface is 
relevant for the efficiency of bacterial attachment.
Bacteria transiently expressing FHA, but not ACT, during 
phase modulation showed similar attachment ratios as ACT- 
deficient strains. In agreement with previous studies, the 
expression of FHA was detected earlier than ACT expression 
after changing to nonmodulating conditions. Attachment 
ratios increased in parallel with ACT expression. Interest­
ingly, Edwards et al. (2005) observed that B. bronchiseptica 
strains lacking adenylate cyclase-hemolysin toxin dis­
played an ‘intermediate’ level of attachment to a rabbit 
tracheal epithelial cell, i.e. in between that of Bvg+ and 
Bvg — strains.
A direct role of ACT as an adhesin could not be demon­
strated. Bordetella pertussis lacking the expression of all Bvg- 
regulated virulence factors attached to epithelial cells in a 
way similar to the isogenic FHA mutant strain suggesting 
that FHA, but not ACT or any other Bvg-regulated virulence 
factor, acts as an adhesin under the experimental conditions 
used in this study. Consequently, the presence of polyclonal 
anti-ACT did not modify the attachment of wild-type or 
FHA deficient mutant strains to respiratory epithelial cells. 
These data suggest that ACT does not display adhesive 
activity.
Increases in intracellular cAMP could induce changes in 
the target cell which might eventually lead to an increase of 
bacterial attachment. To investigate this possibility we used 
blocking monoclonal antibodies against either AC or Hly 
activities of ACT. None of the blocking monoclonal anti­
bodies decreased adherence of wild-type bacteria indicating 
that ACT enzymatic activities are not involved in the 
attachment of B. pertussis to epithelial cells. Gray et al. 
(2004) reported that blocking AC toxin activity by the use 
of a monoclonal antibody abolished the induction of high 
levels of cAMP in mouse monocytes but did not influence 
B. pertussis attachment. Similarly, Ishibashi et al. (2001) 
showed that the level of cell-associated B. pertussis mutant 
expressing inactive ACT on the bacterial membrane was 
comparable to that exhibited by wild-type strains. Taken 
together, these results seem to exclude the idea that enzy­
matic activities of ACT influence bacterial attachment.
The reported association of ACT and FHA on the 
bacterial surface raises the possibility that ACT expression 
facilitates FHA-mediated bacterial binding. FHA is a multi­
functional adhesin with several docking molecules, includ­
ing lactosyl ceramides of ciliated respiratory cells, sulphated 
sugars at the surface of epithelial cells and extracellular 
matrix, and integrins on leukocytes. Menozzi et al. (1994) 
have shown that the heparin-inhibitable binding activity of 
FHA is primarily responsible for the attachment of B. 
pertussis to epithelial cells. Attachment levels of the wild­
type strain decreased to the level of the FHA-deficient 
mutant, whereas adherence of the FHA-deficient strain was 
not further modified by the presence of heparin. Interest­
ingly, heparin did not significantly modify the attachment 
rates of the ACT-defective strain. These results suggest that 
the ACT modifies and amplifies the FHA function, presum­
ably by inducing a conformational change that involves, at 
least, one of the binding domains. The lack of ACT seems to 
modify FHA-cells interaction in a way that is less efficient in 
mediating bacterial attachment but no longer inhibitable by 
heparin. Heparin and heparan sulphates are abundant in 
extracellular matrices and interact with many eukaryotic 
proteins which regulate important physiological processes. 
Heparan sulphate is present on the surface of almost all 
animal cells.
Published data seem to indicate that the differential 
regulation of Bvg-activated virulence factors plays a role in 
B. pertussis pathogenesis (Kinnear et al., 2001; Vergara- 
Irigaray et al., 2005). A recently reported study (Veal-Carr 
& Stibitz, 2005) further supports this hypothesis and sug­
gests that the Bvg1 phase is important during infection. This 
phenotype is characterized by the expression of FHA but not 
ACT. The resulting change in functionality of surface 
associated FHA in the absence of ACT expression might 
be relevant during infection, when sulphated polysacchar­
ides are present in large amounts, e.g. in mucus of the 
respiratory tract.
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